Estats Units - anglès - NLM (National Library of Medicine)

avera mckennan hospital - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic, anhydrous 852 mg

Estats Units - anglès - NLM (National Library of Medicine)

kaiser foundation hospitals - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic, anhydrous 852 mg

Estats Units - anglès - NLM (National Library of Medicine)

cardinal health - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic, anhydrous 852 mg

Estats Units - anglès - NLM (National Library of Medicine)

icu medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), monobasic potassium phosphate (unii: 4j9fj0hl51) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v8k8hr), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37, phosphate ion - unii:nk08v8k8hr) - ionosol mb and 5% dextrose injection is indicated for intravenous administration to infants for treatment of dehydration, acidosis, diarrhea, and burns, but only after administration of an initial priming solution: 15 ml of 5% dextrose and 0.45% sodium chloride injection/kg of body weight. in adults, ionosol mb and 5% dextrose injection is indicated postoperatively for intravenous fluid and electrolyte maintenance therapy, with a small amount of carbohydrate calories for reducing catabolism of endogenous protein reserves. solutions containing potassium are contraindicated in diseases where high potassium levels may be encountered.

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - glycine; citric acid monohydrate; glucose; potassium citrate; potassium phosphate monobasic; sodium chloride - oral solution/suspension - glycine amino acid-glycine active 38.56 g/l; citric acid monohydrate acid-general active 3.28 g/l; glucose carbohydrate active 278.75 g/l; potassium citrate mineral-potassium active 0.75 g/l; potassium phosphate monobasic mineral-potassium active 25.53 g/l; sodium chloride mineral-sodium-salt active 53.44 g/l - alimentary system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - animal - debilitated condition | dehydration | diarrhoea | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | postweaning scours | prophylactic | scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - glycine; citric acid anhydrous; glucose anhydrous; potassium citrate; potassium phosphate monobasic; sodium chloride - oral powder, pre-mix - glycine amino acid-glycine active 6.18 g/sa; citric acid anhydrous acid-general active 0.48 g/sa; glucose anhydrous carbohydrate active 44.61 g/sa; potassium citrate mineral-potassium active 0.12 g/sa; potassium phosphate monobasic mineral-potassium active 4.08 g/sa; sodium chloride mineral-sodium-salt active 8.58 g/sa - alimentary system - calf | cat | dog | horse foal | lamb | pigs | beef calf | bitch | boar | bovine | calf - poddy | calf - preweaning | calf - suck - dehydration | scours | stress | selenium responsive scours

Estats Units - anglès - NLM (National Library of Medicine)

uriel pharmacy inc. - silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4), potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), ferrous sulfate (unii: 39r4tan1vt) (ferrous cation - unii:gw89581owr) - potassium phosphate, monobasic 6 [hp_x] - directions: for oral use only. uses: temporary relief of nervousness and exhaustion.

Estats Units - anglès - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, monobasic, monohydrate 276 mg in 1 ml - sodium phosphates injection, usp is indicated as a source of phosphate, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake.  it is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. the concomitant amount of sodium (4 meq/ml) must be calculated into total electrolyte dose of such prepared solutions. sodium phosphate is contraindicated in diseases where high phosphate or low calcium levels may be encountered, and in patients with hypernatremia.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - monobasic potassium phosphate, quantity: 109.33 mg/ml; dibasic potassium phosphate, quantity: 105.33 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - indications as at 01 january 1991 : treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. lowering the ph of urine. the treatment of potassium depletion in patients with hypokalemia. iv administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium phosphate monobasic ; sodium phosphate dibasic dihydrate ; potassium hydroxide - concentrate for soln for inf - 170. 133.5 14.0 g/20ml - combinations of electrolytes